Ian Waddell

Ian Waddell has a diverse and extensive work experience in the field of oncology and drug discovery. Ian is currently serving as the Chief Executive Officer at Nodus Oncology, a position they have held since September 2022. Prior to this, they worked as the Chief Scientific Officer at Cumulus Oncology starting from March 2022.

In 2021, Ian founded their own consulting firm, 25IDW Consulting Services Ltd. Prior to that, they held various positions at Charles River Laboratories, including Chief Scientific Officer (Early Discovery) and Executive Director of Biology. At Charles River Laboratories, they led a large team of biologists and was responsible for delivering quality drug discovery projects.

Before their tenure at Charles River Laboratories, Ian worked at the Cancer Research UK Manchester Institute as the Head of Biology in the Drug Discovery Unit. Ian led a multidisciplinary team of biologists and focused on investigating novel drug discovery targets for cancer treatment.

Ian also has experience in consulting for the biotech industry. Ian worked as a Director at ZAPERO Ltd and provided consultancy services to small to medium biotech companies. In addition, they served on scientific advisory boards and acted as a consultant for several biotech companies.

Their earlier experience includes roles at Astrazeneca, where they held positions such as Bioscience Director, Director of Lead Optimization, and Associate Director and Project Manager. In these roles, they were responsible for delivering bioscience needs for various drug discovery projects in the fields of oncology, diabetes, and obesity.

Ian's career began at the University of Dundee, where they worked as a Lecturer in Molecular Medicine. Ian conducted research in hepatic carbohydrate metabolism and taught courses for MRes and Medical Students.

Overall, Ian Waddell has a strong background in drug discovery, including leadership positions, consultancy work, and academic experience. Their expertise lies in oncology, diabetes, and obesity research.

Ian Waddell's education begins with their time at Morgan Academy from 1974 to 1980. However, no specific degree or field of study is provided for this period. Ian then pursued a Bachelor of Science degree in biochemistry at the University of Dundee from 1981 to 1985. After completing their undergraduate studies, Waddell continued their education at the University of Dundee, where they obtained a PhD in molecular medicine from 1985 to 1988. Lastly, in 2009 to 2010, they attended Villanova University to earn a Lean Six Sigma Black Belt degree in Organizational Leadership.